Michael Kelleher

TL;DR: Adverse drug events are common and often preventable among older persons in the ambulatory clinical setting and prevention strategies should target the prescribing and monitoring stages of pharmaceutical care.

TL;DR: Information is gathered on patient‐level factors associated with risk of adverse drug events (ADEs) that may allow focus of prevention efforts on patients at high risk.

TL;DR: Efforts are required to reduce "therapeutic inertia," particularly in patients with modestly elevated systolic blood pressure levels, particularly in users of the antihypertensive drug regimen.

TL;DR: The findings emphasize the limitations of voluntary reporting by health care providers as the principal means for detection of ADEs and suggest that multiple strategies are required to detect ADEs in geriatric ambulatory patients.

TL;DR: Deyo et al. as discussed by the authors defined "SpPin" as an acronym to remind the clinician that "when specificity is extremely high, a positive test result rules in the target disorder." But their own data demonstrate that one can have a very high test specificity without a high positive predictive value.